Clinical trial · Interventional
Analgesic Effects of Retro-superior Costotransverse Ligament Space Block for Video-assisted Thoracoscopic Surgery
Postoperative Analgesic Effects of Ultrasound-guided Retro-superior Costotransverse Ligament Space Block After Video-assisted Thoracoscopic Surgery: a Prospective Randomized Controlled Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this clinical trial is to investigate the effects of postoperative analgesia during retro-SCTLB(retro superior costotransverse ligament space block) and TPVB(thoracic paravertebral block) in patients undergoing thoracoscopic radical resection of lung cancer。By comparing the dosage of opioid drugs after surgery, the impact of retro-SCTLB and TPVB on the postoperative analgesic effect was evaluated.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Nerve Block | — | UNRESOLVED | — |
| Thoracoscopic Radical Resection of Lung Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ultrasound-guided retro-SCTLB | Procedure | — | UNRESOLVED |
| Ultrasound-guided TPVB | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- retro-SCTLB group
- description
- A total of 20 ml of the 0.375% ropivacaine is injected in the retro-superior costotransverse ligament space in the retro-SCTLB group。
- interventionNames
- Procedure: Ultrasound-guided retro-SCTLB
- type
- EXPERIMENTAL
- label
- TPVB group
- description
- A total of 20 ml of the 0.375% ropivacaine is injected in the paravertebral space in the TPVB group .
- interventionNames
- Procedure: Ultrasound-guided TPVB
Primary outcomes (1)
- measure
- Postoperative sufentanil dosage
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients scheduled for thoracoscopic radical lung cancer surgery under general anesthesia； * aged 18-80 years； * BMI 18-30 kg/m²； * ASA classification I-III； Exclusion Criteria: * Allergy to the study drug or local anesthetic; * History of opioid abuse; * Pre-existing skin infection at the puncture site of ITPN or TPVB; * Peripheral infectious neuropathy; * Dysfunction of blood coagulation;
References
Publications (0)
Data not yet available